Is fenofibrate a cost-saving treatment for middle-aged individuals with type 2 diabetes? A South African private-sector perspective
نویسنده
چکیده
INTRODUCTION This project was based on the FIELD trial. It is a localisation of the study by Carrington and Stewart. The aim of the original study was to determine the impact of fenofibrate therapy on healthcare costs of middle-aged patients with type 2 diabetes at high risk of future cardiovascular events. METHODS The methodology used in the Carrington article was adopted for this study. The clinical foundation for the analysis was derived from the findings of the FIELD study. All costs were sourced from electronic databases obtained from private-sector South African funders of healthcare. Event costs for the cardiovascular events were determined and added to the treatment costs for the individual treatment arms. The cost saving was determined as the difference between the event costs saved and the additional treatment costs associated with fenofibrate treatment. All costs were reported as 2008 ZAR and a discount rate of 10% was used. The study adopted a South African private-sector funder perspective. RESULTS If the same approach is followed as in the Carrington and Stewart study, a cost saving of 18% results. This is the difference between the total costs associated with the placebo and fenofibrate arms, respectively (R3 480 471 compared to R2 858 598 per 1 000 patient years for the placebo and fenofibrate arms, respectively). The total costs were determined as the sum of associated event costs and treatment costs for each of the comparators. CONCLUSIONS Based on this exploratory analysis, it seems that Lipanthyl treatment in middle-aged patients resulted in a cost saving due to the prevention of cardiovascular events when it was used in the treatment of type 2 diabetics, as in the FIELD study. It should therefore be considered to be cost effective, even when just the cardiovascular risk reduction effect is considered.
منابع مشابه
Applying a private sector capitation model to the management of type 2 diabetes in the South African public sector: a cost-effectiveness analysis
BACKGROUND Diabetes mellitus contributes substantially to the non-communicable disease burden in South Africa. The proposed National Health Insurance system provides an opportunity to consider the development of a cost-effective capitation model of care for patients with type 2 diabetes. The objective of the study was to determine the potential cost-effectiveness of adapting a private sector di...
متن کاملAuthor's response to reviews Title:Applying a private sector capitation model to the management of type 2 diabetes in the South African public sector: a cost-effectiveness analysis. Authors:
متن کامل
Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.
To the Editor: Although access to highly active antiretroviral treatment (HAART) in the South African public health sector is closely monitored,1 much remains unknown regarding the numbers of HIV-positive individuals receiving HAART outside the public health sector. Access to HAART in the private health sector is probably considerably better than in the public health sector, as private sector p...
متن کاملComparative effectiveness and cost-effectiveness of target- versus benefit-based treatment of type 2 diabetes in low- and middle-income countries
BACKGROUND Optimal prescription of blood pressure, lipid, and glycaemic control treatments for adults with type 2 diabetes remains unclear. We aimed to compare the effectiveness and cost-effectiveness of two treatment approaches for diabetes management in five low-income and middle-income countries. METHODS We developed a microsimulation model to compare a treat-to-target (TTT) strategy, aimi...
متن کاملDevelopment and psychometric properties of perceived barriers scale (PBS) for self-care in middle-aged patients with diabetes mellitus type 2
Appropriate self-care has an important role in improving the life level of diabetics and it has been proven that perceived barriers is one of the most contributory factors on the success self-carein diabetes. Thus, this study aimed to develop a scale for evaluating perceived barriers for self-care in middle-aged patients with diabetes mellitus type 2. The qualitative part of this mixed study wa...
متن کامل